Xiaobing Li resumes & CV records
Resumes
Xiaobing Li
Location:
Princeton, NJ
Industry:
Financial Services
Xiaobing Li
Xiaobing Li
Xiaobing Li, 554345 Province Line Rd, Princeton, NJ 08540
Xiaobing Li Phones & Addresses
4345 Province Line Rd, Princeton, NJ 08540 609-9210727
Belle Mead, NJ
Flushing, NY
West New York, NJ
Santa Monica, CA
Mentions for Xiaobing Li
Publications & IP owners
Us Patents
Arylsubstituted Piperazines Useful In The Treatment Of Benign Prostatic Hyperplasia
US Patent:
6303594, Oct 16, 2001
Filed:
Mar 15, 2000
Appl. No.:
9/526224
Inventors:
Linda Jolliffe - Belle Mead NJ
William Murray - Belle Mead NJ
Virginia Pulito - Flemington NJ
Allan Reitz - Lansdale PA
Xiaobing Li - San Diego CA
Linda Mulcahy - Flemington NJ
Cynthia Maryanoff - Forest Grove PA
Frank Villani - Perkasie PA
William Murray - Belle Mead NJ
Virginia Pulito - Flemington NJ
Allan Reitz - Lansdale PA
Xiaobing Li - San Diego CA
Linda Mulcahy - Flemington NJ
Cynthia Maryanoff - Forest Grove PA
Frank Villani - Perkasie PA
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
A61K 3155
A61K 31496
C07D40112
C07D40312
A61K 31496
C07D40112
C07D40312
US Classification:
51421208
Abstract:
This invention relates to a series of arylsubstituted piperazines, of Formula I ##STR1## pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention selectively inhibit binding to the. alpha. -1a adrenergic receptor, a receptor which has been implicated in benign prostatic hyperplasia. As such the compounds are potentially useful in the treatment of this and other disease.
Arylsubstituted Piperazines Useful In The Treatment Of Benign Prostatic Hyperplasia
US Patent:
6593474, Jul 15, 2003
Filed:
Jun 12, 2000
Appl. No.:
09/591814
Inventors:
Linda Jolliffe - Belle Mead NJ
William Murray - Belle Mead NJ
Virginia Pulito - Flemington NJ
Linda Mulcahy - Flemington NJ
Xiaobing Li - San Diego CA
Allen Reitz - Lansdale PA
Cynthia Maryanoff - Forest Grove PA
Frank Villani - Perkasie PA
William Murray - Belle Mead NJ
Virginia Pulito - Flemington NJ
Linda Mulcahy - Flemington NJ
Xiaobing Li - San Diego CA
Allen Reitz - Lansdale PA
Cynthia Maryanoff - Forest Grove PA
Frank Villani - Perkasie PA
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
C07D29514
US Classification:
544393, 544230, 544360, 544372, 544373, 544392
Abstract:
This invention relates to a series of arylsubstituted piperazines, of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention selectively inhibit binding to the -1 adrenergic receptor, a receptor which has been implicated in benign prostatic hyperplasia. As such the compounds are potentially useful in the treatment of this and other disease.
Pyridone Compounds As Inhibitors Of Bacterial Type Iii Protein Secreation Systems
US Patent:
7087622, Aug 8, 2006
Filed:
May 6, 2005
Appl. No.:
11/123995
Inventors:
Xiaobing Li - Flemington NJ, US
Assignee:
Janssen Pharmaceutica N.V. - Beerse
International Classification:
C07D 211/84
A61K 31/44
A61K 31/44
US Classification:
514319, 546297
Abstract:
In accordance with the present invention, compounds that inhibit Type III protein section have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of Type III protein section and/or in the treatment and prevention of bacterial infections, particularly Gram-negative bacterial infections, are provided. In another aspect of the invention, methods are provided for the inhibition of Type III protein secretion and/or the treatment and prevention of bacterial infections, particularly Gram-negative bacterial infections using the compounds of the invention.
Octahydro-Indolizine And Quinolizine And Hexahydro-Pyrrolizine
US Patent:
2003001, Jan 16, 2003
Filed:
Sep 21, 2001
Appl. No.:
09/960031
Inventors:
Richard Apodaca - San Diego CA, US
Nicholas Carruthers - Poway CA, US
John Carson - Norristown PA, US
Wenying Chai - San Diego CA, US
Annette Kwok - San Diego CA, US
Xiaobing Li - Belle Mead NJ, US
Timothy Lovenberg - San Diego CA, US
Dale Rudolph - San Diego CA, US
Chandravadan Shah - San Diego CA, US
Nicholas Carruthers - Poway CA, US
John Carson - Norristown PA, US
Wenying Chai - San Diego CA, US
Annette Kwok - San Diego CA, US
Xiaobing Li - Belle Mead NJ, US
Timothy Lovenberg - San Diego CA, US
Dale Rudolph - San Diego CA, US
Chandravadan Shah - San Diego CA, US
International Classification:
A61K031/4745
A61K031/407
C07D495/02
A61K031/407
C07D495/02
US Classification:
514/306000, 514/412000, 546/138000, 548/453000
Abstract:
The invention features substituted fused bicyclic compounds, pharmaceutical compositions containing them, and methods of using them to treat or prevent histamine-mediated diseases and conditions.
Arylsubstituted Piperazines Useful In The Treatment Of Benign Prostatic Hyperplasia
US Patent:
2003022, Nov 27, 2003
Filed:
Jun 2, 2003
Appl. No.:
10/452255
Inventors:
Linda Jolliffe - Belle Mead NJ, US
William Murray - Belle Mead NJ, US
Virginia Pulito - Flemington NJ, US
Allen Reitz - Landsdale PA, US
Xiaobing Li - San Diego CA, US
Linda Mulcahy - Flemington NJ, US
Cynthia Maryanoff - Forest Grove PA, US
Frank Villani - Perkasie PA, US
William Murray - Belle Mead NJ, US
Virginia Pulito - Flemington NJ, US
Allen Reitz - Landsdale PA, US
Xiaobing Li - San Diego CA, US
Linda Mulcahy - Flemington NJ, US
Cynthia Maryanoff - Forest Grove PA, US
Frank Villani - Perkasie PA, US
International Classification:
C 07D 4 3/02
US Classification:
540/598000, 544/360000, 544/359000, 544/372000, 544/373000
Abstract:
This invention relates to a series of arylsubstituted piperazines, of Formula I pharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention selectively inhibit binding to the -1a adrenergic receptor, a receptor which has been implicated in benign prostatic hyperplasia. As such the compounds are potentially useful in the treatment of this and other disease.
Octahydro-Indolizine And Quinolizine And Hexahydro-Pyrrolizine
US Patent:
2004016, Aug 26, 2004
Filed:
Feb 6, 2004
Appl. No.:
10/773808
Inventors:
Richard Apodaca - San Diego CA, US
Nicholas Carruthers - Poway CA, US
John Carson - Norristown PA, US
Wenying Chai - San Diego CA, US
Annette Kwok - San Diego CA, US
Xiaobing Li - Belle mead NJ, US
Timothy Lovenberg - San Diego CA, US
Dale Rudolph - San Diego CA, US
Chandravadan Shah - San Diego CA, US
Nicholas Carruthers - Poway CA, US
John Carson - Norristown PA, US
Wenying Chai - San Diego CA, US
Annette Kwok - San Diego CA, US
Xiaobing Li - Belle mead NJ, US
Timothy Lovenberg - San Diego CA, US
Dale Rudolph - San Diego CA, US
Chandravadan Shah - San Diego CA, US
International Classification:
C07D455/02
US Classification:
546/138000
Abstract:
The invention features substituted fused bicyclic compounds, pharmaceutical compositions containing them, and methods of using them to treat or prevent histamine-mediated diseases and conditions.
Inhibitors Of Bacterial Type Iii Protein Secretion Systems
US Patent:
2005025, Nov 10, 2005
Filed:
May 6, 2005
Appl. No.:
11/124008
Inventors:
Xiaobing Li - Flemington NJ, US
Mark Macielag - Branchburg NJ, US
Mark Macielag - Branchburg NJ, US
International Classification:
C07D211/72
C07D207/22
A61K031/16
C07D207/22
A61K031/16
US Classification:
514352000, 514616000, 564153000, 546308000, 548557000, 514426000
Abstract:
In accordance with the present invention, compounds that inhibit Type III protein section have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of Type III protein section and/or in the treatment and prevention of bacterial infections, particularly Gram-negative bacterial infections, are provided. In another aspect of the invention, methods are provided for the inhibition of Type III protein secretion and/or the treatment and prevention of bacterial infections, particularly Gram-negative bacterial infections using the compounds of the invention.
Triazine Compounds As Inhibitors Of Bacterial Type Iii Protein Secretion Systems
US Patent:
2005025, Nov 10, 2005
Filed:
May 6, 2005
Appl. No.:
11/124009
Inventors:
Xiaobing Li - Flemington NJ, US
Fu-An Kang - Belle Mead NJ, US
Mark Macielag - Branchburg NJ, US
Fu-An Kang - Belle Mead NJ, US
Mark Macielag - Branchburg NJ, US
International Classification:
C07D043/02
US Classification:
544209000, 544212000
Abstract:
In accordance with the present invention, compounds that inhibit Type III protein section have been identified, and methods for their use provided. In one aspect of the invention, compounds useful in the inhibition of Type III protein section and/or in the treatment and prevention of bacterial infections, particularly Gram-negative bacterial infections, are provided. In another aspect of the invention, methods are provided for the inhibition of Type III protein secretion and/or the treatment and prevention of bacterial infections, particularly Gram-negative bacterial infections using the compounds of the invention.
Isbn (Books And Publications)
Mao'S Generals Remember Korea
Author:
Xiaobing Li
ISBN #:
0700610952
Voices From The Korean War: Personal Stories Of American, Korean And Chinese Soldiers
Author:
Xiaobing Li
ISBN #:
0813122937
China And The United States: A New Cold War History
Author:
Xiaobing Li
ISBN #:
0761809775
China And The United States: A New Cold War History
Author:
Xiaobing Li
ISBN #:
0761809783
Interpreting U.s. China--Taiwan Relations: China In The Post-Cold War Era
Author:
Xiaobing Li
ISBN #:
0761811214
Korea And Regional Geopolitics
Author:
Xiaobing Li
ISBN #:
0761812547
Interpreting U. S.-China-Taiwan Relations: China In The Post-Cold War Era
Author:
Xiaobing Li
ISBN #:
0761818995
Taiwan In The Twenty-First Century
Author:
Xiaobing Li
ISBN #:
0761826297
Possible Relatives
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.